Projel-20
Natural health product licensed in Canada
- Licence holder
- Novocol Pharmaceutical of Canada, Inc.
- NPN or DIN-HM
- 80036476
- Status
- Active licence
- Licence date
- 13 October 2012
- Revision date
- Not provided
- Form
- Gel
- Route of administration
- Oromucosale
- Application type
- Non traditionnelle
Oral dose analysis does not apply without an established exclusively oral route.
Composition
Medicinal composition not provided.
Non-medicinal ingredients
Poly(éthylène glycol), Sacharinate de sodium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes et enfants | minimum: 2 years | Not specified | minimum: 1 day ; maximum: 4 days |
Uses authorised in Canada
Temporary pain relief of oral mucosa due to minor irritation or injury of the mouth and gums or of pain associated with canker sores, dentures or othodontic appliances. For topical application to oral mucosa only.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Use smallest amount possible to achieve desired result. Do not use for more than 7 days unless directed by a dentist or physician. For occasional use only. Do not exceed recommended dosage. Avoid contact with eyes; if this happens, rinse thoroughly with water. Use with caution in children. Keep out of reach of children. Apply to the affected area, wait until relief is obtained, and rinse the mouth before reinserting the appliance. Contact a dentist at regular intervals when using this product to relieve pain during adjustment of new dentures or other dental appliances. Do not eat for one hour following use. Do not chew gum or food while numbness persists.
Source
Official Health Canada record, licence 80036476
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.